Study to Investigate the Pharmacokinetic Profile

NCT03286829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

DRUG: Tesomet "High dose" in fasted condition
DRUG: Tesomet "Low dose" in fasted condition
DRUG: Comperator 1 mg tesofensine, 25 mg commercial IR metoprolol, 75 mg commercial ER metoprolol, fasted condition.
DRUG: Tesomet "High dose" in fed condition

Sponsor

Saniona